Silo Pharma shareholders approve 37.5x increase in authorized shares to 250M

Silo Pharma, Inc.

Shareholders approved increase in authorized common stock from 6,666,667 to 250,000,000 shares on Aug 14, 2026.
Vote: 498,224 for, 190,599 against, 8,485 abstain; no broker non-votes.
Directors re-elected: Eric Weisblum, Wayne Linsley, Kevin Munoz, Jeff Pavell; each received ~359k for votes.
Ratified Salberg & Company as independent auditor for FY2026; 690,743 for, 2,571 against.
Adjournment proposal approved 556,797 for, 131,873 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.